On this coming Sunday at sundown until Monday at sundown, Jewish people observe Yom Kippur, arguably the holiest of holidays. It is a day of reflection on one’s character, responsibilities, and behavior, and regret and contrition for slights and offense one may have caused during the past year. We end the prayers with “May you be inscribed in the Book of Life for a Good Year.”
And a good year and longer and better life is what Israel’s researchers work for around the clock and every single day, to benefit billions of citizens on every continent. Michael Ordman details these astonishing contributions. May he and good people of every faith be inscribed and prosper from the fruits of Israel’s Labor. “G’mar chatima tova” rsk
www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
Better together. Researchers at Israel’s Technion have developed an AI system that identified 77 approved cancer nano-therapies that can chemically self-assemble in nearly 2,000 combinations to be far more effective, with less side-effects. They proved their system, combining bortezomib-cabozantinib to treat head/neck cancer.
https://nocamels.com/2023/09/new-ai-tool-combines-cancer-drugs-to-optimize-treatment/
https://www.israel21c.org/ai-matchmaker-heralds-new-era-in-nano-cancer-treatment/
https://www.sciencedirect.com/science/article/abs/pii/S0168365923004236?dgcid=author
Woman saved from deadly skin-peeling disease. A woman with Stevens-Johnson Syndrome (SJS) was saved by doctors at Soroka-University Medical Center in Beersheba. The genetic disease progresses into toxic epidermal necrolysis – a life threatening condition causing 30% of the skin to peel off.
https://www.jpost.com/health-and-wellness/article-756591
Positive results in bladder cancer trial. Israel’s UroGen Pharma (see here previously) has published positive results from two clinical trials of bladder cancer treatment UGN-102. The therapy can benefit some 80,000 patients. Trial success (65%) was similar to patients who had surgery but with a 55% less re-occurrence rate.
https://en.globes.co.il/en/article-urogen-to-raise-120m-after-positive-bladder-cancer-trial-results-1001453726
Nasal spray combats allergic reactions. (TY Atid-EDI) Israel’s Nasus Pharma (see here previously) has reported positive results from its latest clinical study of its FMXIN002 intranasal Epinephrine powder spray device. It provides a safe and effective rescue for the emergency treatment of life-threatening allergic reactions.
https://www.prnewswire.com/news-releases/nasus-pharma-announces-publication-of-its-positive-clinical-results-with-fmxin002-intranasal-powder-epinephrine-spray-in-the-journal-of-allergy-and-clinical-immunology-in-practice-301895372.html https://pubmed.ncbi.nlm.nih.gov/37394178/
MS treatment commercialized. GranaGard Nano Omega 5, made by Israel’s Granalix Biotechnologies, is now available in Israel and online. The nano-engineered high antioxidant supplement from pomegranate oil (see previously) improves cognitive function in Multiple Sclerosis patients and will be tested on dementia patients.
https://www.timesofisrael.com/nano-engineered-pomegranate-oil-holds-hope-for-brain-disease-study-shows/
https://il.granalix.com/en/ https://www.sciencedirect.com/science/article/abs/pii/S2211034821003709
https://www.youtube.com/watch?v=U8ef3JpVl90
EU funds trial for preemie insulin. Israel’s Elgan Pharma (see here previously) has been awarded a 2.36 million euros grant by the European Innovation Council. It will support a Phase III study of its ELGN-GL oral insulin-based formulation that helps the development of a preemie’s gastrointestinal (GI) system.
https://www.timesofisrael.com/israeli-company-nears-final-hurdle-to-okay-insulin-based-preemie-therapy/
US approval for cancer treatment software. (TY Atid-EDI) Israel’s Techsomed (see here previously) has received US FDA approval for its Ablation Treatment Planning and Confirmation Software. VisAble.IO helps guide surgeons using ablation therapy (extreme heat or cold) to destroy tumors.
https://www.prnewswire.com/news-releases/techsomed-announces-fda-clearance-for-ablation-treatment-planning-and-confirmation-software-301917800.html
US approval for precision endoscope. Israel’s Limaca Medical (see here previously) has received US FDA approval for its Precision GI™ Endoscopic Ultrasound (EUS) Biopsy Device. The device automatically obtains biopsies, for diagnosis of pancreatic cancer and other cancers, quicker and safer than current products.
https://www.prnewswire.com/il/news-releases/limaca-medical-receives-fda-510k-clearance-for-its-breakthrough-precision-gi-endoscopic-biopsy-device-301923165.html